...
首页> 外文期刊>BMC Health Services Research >The social value of a QALY: raising the bar or barring the raise?
【24h】

The social value of a QALY: raising the bar or barring the raise?

机译:QALY的社会价值:提高标准还是禁止提高?

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Since the inception of the National Institute for Health and Clinical Excellence (NICE) in England, there have been questions about the empirical basis for the cost-per-QALY threshold used by NICE and whether QALYs gained by different beneficiaries of health care should be weighted equally. The Social Value of a QALY (SVQ) project, reported in this paper, was commissioned to address these two questions. The results of SVQ were released during a time of considerable debate about the NICE threshold, and authors with differing perspectives have drawn on the SVQ results to support their cases. As these discussions continue, and given the selective use of results by those involved, it is important, therefore, not only to present a summary overview of SVQ, but also for those who conducted the research to contribute to the debate as to its implications for NICE. Discussion The issue of the threshold was addressed in two ways: first, by combining, via a set of models, the current UK Value of a Prevented Fatality (used in transport policy) with data on fatality age, life expectancy and age-related quality of life; and, second, via a survey designed to test the feasibility of combining respondents' answers to willingness to pay and health state utility questions to arrive at values of a QALY. Modelling resulted in values of £10,000-£70,000 per QALY. Via survey research, most methods of aggregating the data resulted in values of a QALY of £18,000-£40,000, although others resulted in implausibly high values. An additional survey, addressing the issue of weighting QALYs, used two methods, one indicating that QALYs should not be weighted and the other that greater weight could be given to QALYs gained by some groups. Summary Although we conducted only a feasibility study and a modelling exercise, neither present compelling evidence for moving the NICE threshold up or down. Some preliminary evidence would indicate it could be moved up for some types of QALY and down for others. While many members of the public appear to be open to the possibility of using somewhat different QALY weights for different groups of beneficiaries, we do not yet have any secure evidence base for introducing such a system.
机译:背景技术自英国国家卫生与临床卓越研究所(NICE)成立以来,一直存在以下问题:NICE使用的每QALY成本阈值的经验依据以及是否应由不同的医疗受益人获得QALY平均加权。本文报告了QALY(SVQ)项目的社会价值,以解决这两个问题。 SVQ的结果是在有关NICE阈值的大量辩论期间发布的,并且有不同观点的作者使用SVQ的结果来支持他们的案例。随着这些讨论的继续进行,并考虑到相关人员有选择地使用结果,因此,重要的是,不仅要提供SVQ的概述,而且对于进行这项研究的人员也要对SVQ的影响做出贡献。不错。讨论阈值问题有两种解决方法:首先,通过一套模型将英国目前的预防死亡价值(用于运输政策)与死亡年龄,预期寿命和与年龄相关的质量数据结合起来生活其次,通过一项旨在检验将受访者对支付意愿的回答与健康状况公用事业问题相结合以得出QALY值的可行性的调查。通过建模,每个QALY的价值在10,000- £ 70,000之间。通过调查研究,大多数汇总数据的方法得出的QALY值为8,00018,000- £ 40,000,尽管其他方法得出的值也高得令人难以置信。另一项针对QALY加权的问题的调查使用两种方法,一种表示不应对QALY加权,另一种是可以对某些群体获得的QALY给予更大的权重。总结尽管我们仅进行了可行性研究和建模练习,但都没有提供令人信服的证据表明可以提高或降低NICE阈值。一些初步证据表明,对于某些类型的QALY,可能会将其调高;对于其他QALY,它可能会调低。尽管许多公众似乎愿意对不同的受益人群体使用一些不同的QALY权重,但我们仍没有任何可靠的证据来引入这种系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号